XML 40 R53.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation (Details) (USD $)
12 Months Ended 12 Months Ended
Aug. 03, 2012
Jul. 29, 2011
Jul. 30, 2010
Aug. 03, 2012
MSU Grants [Member]
Jul. 29, 2011
MSU Grants [Member]
Jul. 30, 2010
MSU Grants [Member]
Aug. 03, 2012
Options [Member]
Jul. 29, 2011
Options [Member]
Jul. 30, 2010
Options [Member]
Aug. 03, 2012
Nonvested Stock [Member]
Jul. 29, 2011
Nonvested Stock [Member]
Jul. 30, 2010
Nonvested Stock [Member]
Aug. 03, 2012
Nonvested Stock [Member]
Minimum [Member]
Aug. 03, 2012
Nonvested Stock [Member]
Maximum [Member]
Jul. 31, 2009
Other Share Based Awards [Member]
Jul. 31, 2009
Other Share Based Awards [Member]
Minimum [Member]
Jul. 31, 2009
Other Share Based Awards [Member]
Maximum [Member]
Aug. 03, 2012
Directors Plan [Member]
Aug. 03, 2012
Employee Plan [Member]
Aug. 03, 2012
Amended and Restated Stock Option Plan [Member]
Aug. 03, 2012
Omnibus Plan 2010 [Member]
Dec. 01, 2010
Omnibus Plan 2010 [Member]
Aug. 03, 2012
Omnibus Plan 2010 [Member]
Options [Member]
Aug. 03, 2012
Long-Term Performance Plan 2010 [Member]
Aug. 03, 2012
Long-Term Performance Plan 2011 [Member]
Aug. 03, 2012
Long-Term Performance Plan 2012 [Member]
Aug. 03, 2012
MSU Grants 2011 [Member]
Aug. 03, 2012
MSU Grants 2012 [Member]
Aug. 03, 2012
Omnibus Plan 2002 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                          
Number of active compensation plans 1                                                        
Number of other compensation plans 4                                                        
Number of shares of the Company's common stock originally authorized for issuance (in shares)                                           1,500,000              
Common stock reserved for future issuance                                         1,256,509                
Number of years to expiration date from grant date (in years)             10 years                     1 year 10 years 10 years                 10 years
Outstanding awards at period end (in shares)             404,000 1,124,000                   16,110 42,546 205,055 374,934               137,384
Option to purchase common stock (in shares)                             25,000                            
Option to purchase nonvested stock grants (in shares)                             25,000                            
Number of nonvested stock grants vest over three years (in shares)                             16,666                            
Number of nonvested stock grants vest over a two-year period (in shares)                             8,334                            
Performance period       three-year                                       2010 2011 - 2012 2012 - 2013      
Stock grants vesting period                         2 years 5 years   2 years 3 years             3 years 2 years 2 years      
Number of shares accrued (in shares)                                                 97,000 140,000 51,000 29,000  
Nonvested Stock [Roll Forward]                                                          
Unvested at beginning of period (in shares)                   339,000                                      
Granted (in shares)                   43,000                                      
Vested (in shares)                   (302,000)                                      
Forfeited (in shares)                   0                                      
Unvested at end of period (in shares)                   80,000 339,000                                    
Weighted-Average Grant Date Fair Value, Nonvested Stock [Abstract]                                                          
Weighted average grant date fair value, unvested at beginning of period (in dollars per share)                   $ 42.31                                      
Weighted average grant date fair value, granted (in dollars per share)                   $ 46.22                                      
Weighted average grant date fair value, vested (in dollars per share)                   $ 42.96                                      
Forfeited (in dollars per share)                   $ 0                                      
Unvested at end of period (in dollars per share)                   $ 41.97 $ 42.31                                    
Fair value of nonvested stock that vested                   $ 12,981,000 $ 4,393,000 $ 2,667,000                                  
Number of executives eligible under the plan       7                                                  
Yearly exercisable cumulative rate (in hundredths)       33.00%                                     33.00%            
Incremental compensation expense         1,221,000                                                
Percentage of shares that may be awarded to the executives, maximum (in hundredths) 150.00%                                                        
Fair Value Assumptions and Methodology [Abstract]                                                          
Dividend yield range (in hundredths)       2.20% 1.60%     1.70% 2.50%                                        
Expected volatility ( in hundredths)       45.00% 43.00%     40.00% 47.00%                                        
Risk-free interest rate, minimum (in hundredths)               0.30% 0.40%                                        
Risk-free interest rate (in hundredths)       0.30% 0.80%                                                
Risk-free interest rate, maximum (in hundredths)               4.60% 5.10%                                        
Expected term               6 years 7 months 6 days 6 years 9 months 18 days                                        
Percentage change in total shareholder return (in hundredths)       141.00% 134.10%                                                
Fixed Options - shares [Roll Forward]                                                          
Outstanding at beginning of period (in shares)             1,124,000                           374,934                
Granted (in shares)             0                                            
Exercised (in shares)             (683,000)                                            
Forfeited (in shares)             (3,000)                                            
Canceled (in shares)             (34,000)                                            
Outstanding at end of period (in shares)             404,000 1,124,000                   16,110 42,546 205,055 374,934               137,384
Exercisable (in shares)             324,000                                            
Fixed Options - Weighted Average Price [Abstract]                                                          
Weighted average price, outstanding at beginning of period (in dollars per share)             $ 33.01                                            
Weighted average price, granted (in dollars per share)             $ 0                                            
Weighted average price, exercised (in dollars per share)             $ 33.45                                            
Weighted average price, forfeited (in dollars per share)             $ 31.58                                            
Weighted average price, canceled (in dollars per share)             $ 21.88                                            
Weighted average price, outstanding at end of period (in dollars per share)             $ 33.22 $ 33.01                                          
Weighted average price, exercisable (in dollars per share)             $ 33.62                                            
Fixed Options - Weighted-Average Remaining Contractual Term [Abstract]                                                          
Weighted-average remaining contractual term, outstanding at end of period (in years)             4 years 4 months 9 days                                            
Weighted average remaining contractual term, exercisable (in years)             3 years 8 months 8 days                                            
Fixed Options - Aggregate Intrinsic Value [Abstract]                                                          
Aggregate intrinsic value, outstanding at end of period             12,014,000                                            
Aggregate intrinsic value, exercisable             9,512,000                                            
Weighted-average grant-date fair values of options granted (in dollars per share)             $ 0 $ 16.81 $ 12.03                                        
Intrinsic values of options exercised             14,859,000 [1] 11,713,000 [1] 21,602,000 [1]                                        
Compensation cost 14,420,000 9,796,000 13,193,000 1,690,000 989,000 0 1,290,000 2,155,000 3,194,000 11,440,000 6,652,000 9,999,000                                  
Total unrecognized compensation       1,761,000     85,000     1,911,000                                      
Weighted average period in years       1 year 7 months 20 days     1 month 6 days     2 years 0 months 14 days                                      
Income tax benefit recognized for share-based compensation 4,254,000 2,576,000 3,470,000                                                    
Number of shares issued from the exercise of share-based compensation awards (in shares) 897,588                                                        
Cash received from the exercise of share-based compensation awards 17,602,000                                                        
Excess tax benefit realized upon exercise of share-based compensation awards 4,502,000                                                        
Cash payment to be paid upon retirement of Executive Chairman $ 900,000                                                        
[1] The intrinsic value for stock options is defined as the difference between the current market value and the grant price.